PMDA drug package insert
ビクトーザ皮下注18mg
PMDA Prescription drug · ノボ ノルディスク ファーマ株式会社 · package insert May 22, 2026
Key facts
| Brand names | ビクトーザ皮下注18mg |
|---|---|
| Nonproprietary names | リラグルチド（遺伝子組換え） |
| Companies | 製造販売元／ノボ ノルディスク ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ヒトGLP-1アナログ注射液 |
| Therapeutic category codes | 872499 |
| YJ codes | 2499410G1021 |
| Approval numbers | 22200AMX00236000 |
| Package insert edition | 第5版 |
| Package insert date | May 22, 2026 |
| PMDA document key | 620023_2499410G1021_1 |
| PMDA company code | 620023 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 10–99 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: